期刊文献+

儿童髓母细胞瘤两年内复发危险因素分析 被引量:1

Risk factors for recurrence within 2 years in children with medulloblastoma
下载PDF
导出
摘要 目的探讨儿童髓母细胞瘤(MB)两年内复发的危险因素及对无进展生存(PFS)率的影响。方法对2017年1~12月收治的123例MB患儿进行回顾性研究,根据复发与否分为复发组(n=30)和非复发组(n=93),分析影响儿童MB两年内复发的危险因素,比较不同因素间的PFS率。结果大细胞/间变型、M分期,均为儿童MB两年内复发的危险因素。分期为M+者,其复发风险为M0的3.525倍;大细胞/间变型复发风险为经典型的3.358倍,差异有统计学意义(P<0.05)。生存分析示分期为M+者,中位PFS期为20个月,M+、M0 20个月PFS率分别为50%±11%、81%±5%(P<0.05)。经典型、促纤维增生/结节型、广泛结节型、大细胞/间变型20个月PFS率分别为80%±5%、65%±10%、86%±13%、36%±20%,不同病理分型之间的PFS率差异有统计学意义(P<0.05)。结论复发是影响儿童MB预后的重要因素,分期为M+及大细胞/间变型MB均为复发的危险因素,且PFS率更低。 Objective To investigate the risk factors for recurrence of medulloblastoma(MB)within 2 years and their influence on progression-free survival(PFS).Methods A retrospective analysis was performed for the clinical data of 123 children with MB who were admitted from January to December,2017.According to the presence or absence of recurrence,they were divided into recurrence group with 30 children and non-recurrence group with 93 children.The risk factors for recurrence within 2 years were analyzed,and PFS was compared between the children with different risk factors.Results Large-cell/anaplastic type and M stage were risk factors for MB recurrence within 2 years.The risk of recurrence in the children with M+MB was 3.525 times that in those with M0 MB,and the risk of recurrence in the children with large-cell/anaplastic MB was 3.358 times that in those with classic MB(P<0.05).The survival analysis showed that the median PFS time was 20 months in the children with M+MB,and the 20-month PFS rate was 50%±11%in the children with M+MB and 81%±5%in those with M0 MB(P<0.05).The 20-month PFS rate was 80%±5%in the children with classic MB,65%±10%in those with desmoplastic/nodular MB,86%±13%in those with MB with extensible nodularity,and 36%±20%in those with large-cell/anaplastic MB(P<0.05).Conclusions Recurrence is an important influencing factor for the prognosis of MB,and M+stage and large-cell/anaplastic MB are risk factors for recurrence.Children with such risk factors tend to have a low PFS rate.
作者 刘晶晶 孙艳玲 杜淑旭 李春德 龚小军 李苗 武万水 孙黎明 LIU Jing-Jing;SUN Yan-Ling;DU Shu-Xu;LI Chun-De;GONG Xiao-Jun;LI Miao;WU Wan-Shui;SUN Li-Ming(Beijing Shijitan Hospital of Capital Medical University,Beijing 100038,China)
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2019年第8期761-765,共5页 Chinese Journal of Contemporary Pediatrics
关键词 髓母细胞瘤 M分期 病理分型 大细胞/间变型 儿童 Medulloblastoma M stage Pathological type Large-cell/anaplastic type Child
  • 相关文献

参考文献2

二级参考文献7

  • 1Gjerris F, Agerlin N, Borgesen SE, et al. Epidemiology and prognosis in children treated for intracranial tumours in Denmark 1960-1984 [J]. Childs Nerv Syst, 1998, 14(7): 302-311.
  • 2Maleci A, Cervoni L, Delfini R. Medulloblastoma in children and in adults: a comparative study [J]. Acta Neurochir, 1992, 119(1-4): 62-67.
  • 3Park TS, Hoffman HJ, Hendrick EB, et al. Medulloblastoma: clinical presentation and management [J]. J Neurosurg, 1983, 58(4): 543-552.
  • 4Gajjar A, Sanford RA, Bhargava R, et al. Medulloblastoma with brain stem involvement: the impact of gross total resection on outcome [J]. Pediatr Neurosurg, 1996, 25(4): 182-187.
  • 5Zhang R, Zhou L. Medulloblastoma [J]. Chin Med J (Engl), 1999, 112(4): 297-301.
  • 6Matsushima T, Inoue T, Inamura T, et al. Transcerebellomedullary fissure approach with special reference to methods of dissecting the fissure [J]. J Neurosurg, 2001, 94(2): 257-264.
  • 7林瑜亮,孙红军,荔志云.不同联合放化疗方式对儿童髓母细胞瘤疗效的系统评价[J].国际神经病学神经外科学杂志,2016,43(1):1-7. 被引量:9

共引文献8

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部